The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Shifting IP Constituencies

19 responses to “Shifting IP Constituencies

  1. Pingback: Biotech Trends Update — IP Constituencies: Endo’s Qualitest Purchase Shows Full Integration of Innovator and Generic Strategies | The Cross-Border Biotech Blog

  2. Pingback: Biotech Trends Update — Biosimilars Blur IP Constituencies: Novartis and Pfizer-Biocon are Featured in the Economist | The Cross-Border Biotech Blog

  3. Pingback: New Firm, New Contributors Contribute to New Look « The Cross-Border Biotech Blog

  4. Pingback: Biotech Trends Update — IP Constituencies: Innovator-Generic Mixing Continues in Canada « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 126 other followers